Meng Liu

Key Laboratory Of Cell Differentiation And Apoptosis Of The Chinese Ministry Of Education
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

JOSD2 regulates PKM2 nuclear translocation and reduces acute myeloid leukemia progression.

JOSD2 regulates PKM2 nuclear translocation and reduces acute myeloid leukemia progression.

Journal: Experimental hematology & oncology
Published: April 12, 2022

IKZF1 selectively enhances homologous recombination repair by interacting with CtIP and USP7 in multiple myeloma.

IKZF1 selectively enhances homologous recombination repair by interacting with CtIP and USP7 in multiple myeloma.

Journal: International journal of biological sciences
Published: January 12, 2022

ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway.

ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway.

Journal: Chemico-biological interactions
Published: December 20, 2020

Hsp90/C terminal Hsc70-interacting protein regulates the stability of Ikaros in acute myeloid leukemia cells.

Hsp90/C terminal Hsc70-interacting protein regulates the stability of Ikaros in acute myeloid leukemia cells.

Journal: Science China. Life sciences
Published: September 27, 2020

Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib.

Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib.

Journal: Cell death & disease
Published: September 26, 2020

Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways.

Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways.

Journal: Acta pharmacologica Sinica
Published: December 31, 2019

USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia.

USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia.

Journal: Signal transduction and targeted therapy
Published: June 26, 2018

Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells.

Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells.

Journal: Cancer biology & therapy
Published: May 01, 2018

Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition.

Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition.

Journal: Cell death & disease
Published: January 24, 2018

Chk1 inhibitors overcome imatinib resistance in chronic myeloid leukemia cells.

Chk1 inhibitors overcome imatinib resistance in chronic myeloid leukemia cells.

Journal: Leukemia research
Published: April 22, 2017

Characterization of naturally occurring pentacyclic triterpenes as novel inhibitors of deubiquitinating protease USP7 with anticancer activity in vitro.

Characterization of naturally occurring pentacyclic triterpenes as novel inhibitors of deubiquitinating protease USP7 with anticancer activity in vitro.

Journal: Acta pharmacologica Sinica
Published: April 05, 2017

Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia.

Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia.

Journal: Nature communications
Published: January 15, 2017
Showing 1-12 of 13

Last Updated: 09/26/2026